Hanmi Pharm. Co., Ltd.
KSC: 128940.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jae-Hyun Park
- Employees
- 2,270
- Headquarters
- Seoul, South Korea
- IPO year
- 2010
- Market cap
- ₩5.5T
- Website
- https://www.hanmipharm.com
Loading 128940…
Loading profile data…Frequently asked questions about 128940
What does Hanmi Pharm. Co., Ltd. (128940.KS) do?
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Where does 128940.KS trade?
Hanmi Pharm. Co., Ltd. (128940.KS) trades on the Korea Exchange.
What sector is 128940.KS in?
Hanmi Pharm. Co., Ltd. (128940.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hanmi Pharm. Co., Ltd.?
Jae-Hyun Park is the chief executive officer of Hanmi Pharm. Co., Ltd. (128940.KS).
Where is Hanmi Pharm. Co., Ltd. headquartered?
Hanmi Pharm. Co., Ltd. is headquartered in South Korea.
Does 128940.KS pay a dividend?
Yes — Hanmi Pharm. Co., Ltd. (128940.KS) paid a trailing twelve-month dividend of KRW 2250.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 128940.KS go public?
Hanmi Pharm. Co., Ltd. (128940.KS) completed its initial public offering in 2010.